Pancreatic Cancer Biomarkers and Their Implication in Cancer Diagnosis and Epidemiology

Cancers

关键词: biomarker;    cancer;    diagnosis;    epidemiology;    epigenetics;    glycans;    methylation index;    pancreas;    prognosis;    sensitivity;    specificity;    survival;    treatment;   

DOI  :  10.3390/cancers2041830

来源: mdpi

【 摘 要 】

Pancreatic cancer is the fourth most common cause of cancer-related mortality in the United States. Biomarkers are needed to detect this cancer early during the disease development and for screening populations to identify those who are at risk. In cancer, “biomarker” refers to a substance or process that is indicative of the presence of cancer in the body. A biomarker might be either a molecule secreted by a tumor or it can be a specific response of the body to the presence of cancer. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers can be used for cancer diagnosis, prognosis, and epidemiology. A number of potential biomarkers have been identified for pancreatic cancer. These markers can be assayed in non-invasively collected biofluids. These biomarkers need analytical and clinical validation so that they can be used for the purpose of screening and diagnosing pancreatic cancer and determining disease prognosis. In this article, the latest developments in pancreatic cancer biomarkers are discussed.

【 授权许可】

CC BY   
© 2010 by the authors; licensee MDPI, Basel, Switzerland.